Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 25 analyst ratings
Buy
Strong Buy 24%
Buy 56%
Hold 12%
Sell 8%
Strong Sell 0%

Bulls say

UnitedHealth Group is a global leader in providing medical insurance and healthcare services, with a strong presence in employer-sponsored, self-directed, and government-backed plans. With its massive scale and diversified offerings through its UnitedHealthcare and Optum segments, the company is well-positioned for long-term growth. Factors contributing to this positive outlook include solid financials, strong leadership, investments in emerging technologies, and strategic initiatives such as the recent sale of Optum UK and the acquisition of Alegeus Technologies. However, potential downside risks include Medicare reimbursement reductions and increased competition. With a strong start to 2026 and raised FY26 guidance, UNH's stock is expected to continue to perform well in the near future.

Bears say

UnitedHealth Group is facing risks from potential increases in commercial and Medicaid costs, regulatory scrutiny, and the year 3 phase-in of v28 risk model changes, leading to negative pressure on margins. The company’s investments in AI could potentially generate margin and growth benefits, but the majority of these effects will be weighted towards the end of 2026 and 2027. Additionally, there are risks associated with UnitedHealth Group's government exposure, continued care activity trends, regulatory changes, and competition.

UnitedHealth Group (UNH) has been analyzed by 25 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 56% recommend Buy, 12% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 25 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $378.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $378.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.